Anecortave Acetate in Patients With Open-Angle Glaucoma

This study has been completed.

First Received: May 1, 2006 Last Updated: February 29, 2008 History of Changes

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00320203

Purpose

Safety, efficacy and duration of effect of Anecortave Acetate for treatment of elevated IOP in patients with open-angle glaucoma

Condition	Intervention	Phase
Open-Angle Glaucoma	Drug: anecortave acetate	Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Anecortave Acetate in Patients With Open-Angle Glaucoma

Resource links provided by NLM:

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma

Drug Information available for: Anecortave acetate

Further study details as provided by Alcon Research:

Primary Outcome Measures:

Secondary Outcome Measures:

Percentage of patients declared treatment failures [ Time Frame: At time point ]

Estimated Enrollment:	81
Study Start Date:	March 2006

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Patients with open-angle glaucoma with a pseudoexfoliation or pigment dispersion component

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00320203

Locations

United States, Texas
US Trial Sites
Fort Worth, Texas, United States, 76134

Sponsors and Collaborators

Alcon Research

Investigators

Study Director:

Theresa Landry

Alcon Research

More Information

No publications provided

Study ID Numbers:	C-04-62
Study First Received:	May 1, 2006
Last Updated:	February 29, 2008
ClinicalTrials.gov Identifier:	NCT00320203 History of Changes
Health Authority:	United States: Food and Drug Administration

Keywords provided by Alcon Research:

open-angle
glaucoma

Study placed in the following topic categories:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Ocular Hypertension

ClinicalTrials.gov processed this record on September 10, 2009